Evidence map›Paper›PMID 23250338›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2013

Inhibitory effect of anethole in nonimmune acute inflammation.

Talita Perdigão Domiciano, Márcia Machado de Oliveira Dalalio, Expedito Leite Silva, Alessandra Mileni Versuti Ritter, Camila Fernanda Estevão-Silva, Fernando Seara Ramos, Silvana Martins Caparroz-Assef, Roberto Kenji Nakamura Cuman, Ciomar Aparecida Bersani-Amado

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. State-Dependent Blockade of Dorsal Root Ganglion Voltage-Gated NaInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Emerging Biopharmaceuticals fromMolecules (Basel, Switzerland) · 2023
    Review
  11. Article
  12. Review
  13. Pharmaceutics · 2022
    Article
  14. Article
  15. Anethole Ameliorates Acetic Acid-Induced Colitis in Mice: Anti-Inflammatory and Antioxidant Effects.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Anticonvulsant Activity ofBioMed research international · 2022
    Article
  17. Frontiers in microbiology · 2022
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Talita Perdigão DomicianoLaboratory of Inflammation, Department of Pharmacology and Therapeutic, State University of Maringá, Maringá, Paraná, Brazil.
Márcia Machado de Oliveira Dalalio
Expedito Leite Silva
Alessandra Mileni Versuti Ritter
Camila Fernanda Estevão-Silva
Fernando Seara Ramos
Silvana Martins Caparroz-Assef
Roberto Kenji Nakamura Cuman
Ciomar Aparecida Bersani-Amado
Universidade Estadual de Maringá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anethole [1-methoxy-4-(1-propenyl)benzene] occurs naturally as a major component of the essential oil of star anise (Illicium verum Hook.f., family Illiciaceae), comprising more than 90 % of its volatile components. Studies showed that this substance has antioxidant, antibacterial, antifungal, and anesthetic properties. In this study, the anti-inflammatory properties of anethole in animal models of nonimmune acute inflammation such as croton oil-induced ear edema and carrageenan-induced pleurisy were investigated. The investigated parameters were edema formation, leukocyte migration, and inflammatory mediators involved. Oral administration of anethole at a dose of 250 and 500 mg/kg reduced both the volume of pleural exudates and the number of migrated leukocytes. Levels of nitric oxide (NO) and prostaglandins (PGE2) in the inflammatory exudate were reduced by treatment with anethole, but levels of tumor necrosis factor-α and interleukin-1β were not significantly altered. In ear edema, the oral treatment with anethole inhibited the formation of exudate and the activity of myeloperoxidase, but not after topical administration. These results suggest that the anethole may be effective in controlling some nonimmune acute inflammation-related disease, probably by an inhibitory action on production and/or release of PGE2 and NO.

Indexed as

Allylbenzene DerivativesAnimalsAnisolesAnti-Inflammatory AgentsCarrageenanCroton OilDinoprostoneEdemaIlliciumInflammationInterleukin-1betaMaleNitratesNitric OxideOils, VolatilePeroxidaseAllylbenzene DerivativesanetholeAnisolesAnti-Inflammatory AgentsCarrageenanCroton OilDinoprostoneInterleukin-1betaNitratesNitric OxideOils, VolatilePeroxidaseTumor Necrosis Factor-alpha

Identifiers

PMID23250338
OpenAlexW2020420839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.